Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
6 rezultatus
Inhalation composition containing lactose pellets
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The present invention relates to an improved pharmaceutical composition, in particular a powder composition suitable for inhalation.
Numerous medicaments, especially those for the treatment of respiratory conditions such as asthma, are administered by inhalation. Since the drug acts directly on the
Inhalation composition containing lactose pellets
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
The present invention relates to an improved pharmaceutical composition, in particular a powder composition suitable for inhalation.
Numerous medicaments, especially those for the treatment of respiratory conditions such as asthma, are administered by inhalation. Since the drug acts directly on the
Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The invention relates to compounds useful in the treatment of inflammation, allergic reactions, autoimmune diseases, and related conditions. More specifically, the invention concerns substituted lactose and lactosamines that bind to the endothelial leukocyte adhesion molecule-1
Lewis-associated compound, process for producing the same, and anti-inflammatory
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This application is filed under 35 U.S.C. .sctn.371 from International Patent Application No. PCT/JP94/00352, filed Mar. 4, 1994.
FIELD OF THE INVENTION
The present invention relates to the method for preparing Lewis-related compounds, especially Lewis x (Le.sup.x) and Lewis a (Le.sup.a) as well as
Substituted lactose and lactosamine derivatives as cell adhesion inhibitors
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The invention relates to compounds useful in the treatment of inflammation, allergic reactions, autoimmune diseases, and related conditions. More specifically, the invention concerns substituted lactose and lactosamines that bind to the endothelial leukocyte adhesion molecule-1
Compositions for dietary health management
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of any one of the disease states in the group consisting of cardiovascular disease, inflammation and diarrhoea.
Human evolution has been a very slow process in contrast to
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
